Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07306793
Eligibility Criteria:
Inclusion Criteria:
* Preterm infants with a postnatal age of 29-33 weeks,
* Whose vital signs and clinical condition have been stable for at least 24 hours,
* Whose APGAR score at 1 and 5 minutes (Activity-Pulse-Grimace-Appearance-Respiration) is 4 or higher.
Exclusion Criteria:
* Infants with major congenital anomalies (such as congenital heart disease, cleft palate, cleft lip) or birth trauma,
* Infants with RDS,
* Infants diagnosed with asphyxia,
* Infants with intraventricular hemorrhage,
* Infants with Neonatal Withdrawal Syndrome,
* Infants with Fetal Alcohol Syndrome,
* Infants included in the study group who develop any complications or whose stable condition deteriorates during the follow-up period,
* Infants with feeding intolerance or who are interrupted from feeding for more than 48 hours,
* Infants who develop sepsis,
* Infants who develop necrotizing enterocolitis,
* Infants receiving mechanical ventilation support,
* Infants who receive narcotic analgesia or sedation,
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
29 Weeks
Maximum Age:
33 Weeks
Study:
NCT07306793
Study Brief:
Protocol Section:
NCT07306793